Ticker
  • Companies
  • RNS
  • AI Chat
  • Research
  • Indices
  • Ticker TV
  • Events
  • Commodities
  • Currencies
Ticker
⌘K
Developer PortalNewsServices

t

t

Company Information

Biopharma Credit PLC

TIDMBPCR
Share PriceLoading...
Market CapLoading...

AI Summary

Sapna Shah, a Director of BioPharma Credit PLC, purchased 14,448 Ordinary Shares of $0.01 each in the company. The transaction occurred on 17 December 2024 on the London Stock Exchange at a price of £0.6921 per share.

RNS Metadata

Date17 Dec 2024
Time15:41:45
CategoryDirector/PDMR dealings
ID4606Q
/Equities/XLON/BPCR/RNS

Director/PDMR Shareholding

RNS Number : 4606Q
BioPharma Credit PLC
17 December 2024
 

BIOPHARMA CREDIT PLC

 

Notification of Transactions by

Persons Discharging Managerial Responsibilities and

Persons Closely Associated with them

 

1.

Details of person discharging managerial responsibilities/person closely associated with them

a)

Name

Sapna Shah

2.

Reason for the notification

a)

Position / status

Director of BioPharma Credit PLC

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

BioPharma Credit PLC

b)

LEI

213800AV55PYXAS7SY24

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares of $0.01 each

 

 

GB00BDGKMY29

b)

Nature of the transaction

Purchase of Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.6921

14,448

d)

Aggregated information

- Aggregated volume

 

- Price

 

 

N/A

 

 

e)

Date of the transaction

17.12.2024

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUBDDIXBDGSR